Replies to post #144449 on Anavex Life Sciences Corp (AVXL)

[Talon38]

Power, Good DD. However, in MHO Dr Aisen would be intimately familiar with all of the successful research and preclinical/clinical trial results noted. Therefore he would be professionally dishonest to continue on the Anavex SAB if he disagreed with the Sigma-1R approach to treating AD. His job now is to help choose 5 to 7 of the most promising drugs in the AD medical research world and bring them under the ACTC support umbrella . The ACTC will be conducting the prototype FDA/CDER Master Protocol "Umbrella Trial" for Alzheimer's starting this year.

My concern is how he may have to handle the question of "conflict of interest" when Anavex 2-73 is put up as a candidate for this "umbrella trial".